Genetic testing for Parkinson’s risks can be useful to people with and without the disease. It can also help advance research into the complex condition. Although the testing…
A new study has refreshed decades-old statistical models for Parkinson’s disease, and in the process discovered that almost 1 million Americans will have the disease in 2020—more than…
A mathematical program developed by Princeton researchers is able to scan through scores of potential peptide drug candidates, accelerating pharmaceutical development.
